NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization
NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC (EIN 95-3018799)
Tax period
2017-01-01 to 2017-12-31
Filed
2018-04-09
IRS object ID
201800999349300410
Schema version
2017v2.3
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-04-09T10:27:59-05:00ReturnTs
Tax Period End2017-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1WITHUMSMITHBROWNPCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14600 EAST WEST HWY 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208143423ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2017-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN953018799EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL TUBEROUS SCLEROSIS ASSOCIATIONBusinessNameLine1Txt
Business Name Line2INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
In Care Of% THE ORGANIZATIONInCareOfNm
Business Name ControlNATIBusinessNameControlTxt
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 ROEDER ROAD Suite 750AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKARI L ROSBECKPersonNm
Person TitlePRESIDENT AND CEOPersonTitleTxt
Phone3015629890PhoneNum
Signature2018-04-04SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJOEL C SUSCOPreparerPersonNm
PTINP00189961PTIN
Phone3012726000PhoneNum
FieldValueIRS element (for citing)
Tax2017TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1TUBEROUS SCLEROSIS ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKARI L ROSBECKPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 ROEDER ROAD STE 750AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$5,018,382GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.TSALLIANCE.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1975FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionTHE TS ALLIANCE IS DEDICATED TO FINDING A CURE FOR TUBEROUS SCLEROSIS COMPLEX WHILE IMPROVING THE LIVES OF THOSE AFFECTED.ActivityOrMissionDesc
Voting Members Governing Body20VotingMembersGoverningBodyCnt
Voting Members Independent20VotingMembersIndependentCnt
Total Employee19TotalEmployeeCnt
Total Volunteers1667TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$4,517,826PYContributionsGrantsAmt
CY Contributions Grants$3,949,953CYContributionsGrantsAmt
PY Program Service Revenue$629,254PYProgramServiceRevenueAmt
CY Program Service Revenue$824,241CYProgramServiceRevenueAmt
PY Investment Income$13,638PYInvestmentIncomeAmt
CY Investment Income$10,221CYInvestmentIncomeAmt
PY Other Revenue$46,841PYOtherRevenueAmt
CY Other Revenue-$41,611CYOtherRevenueAmt
PY Total Revenue$5,207,559PYTotalRevenueAmt
CY Total Revenue$4,742,804CYTotalRevenueAmt
PY Grants And Similar Paid$940,040PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$535,454CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,650,060PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,809,048CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$733,834CYTotalFundraisingExpenseAmt
PY Other Expenses$2,302,337PYOtherExpensesAmt
CY Other Expenses$2,976,795CYOtherExpensesAmt
PY Total Expenses$4,892,437PYTotalExpensesAmt
CY Total Expenses$5,321,297CYTotalExpensesAmt
PY Revenues Less Expenses$315,122PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$578,493CYRevenuesLessExpensesAmt
Total Assets BOY$10,004,341TotalAssetsBOYAmt
Total Assets EOY$9,757,301TotalAssetsEOYAmt
Total Liabilities BOY$738,137TotalLiabilitiesBOYAmt
Total Liabilities EOY$700,521TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$9,266,204NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$9,056,780NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE NATIONAL TUBEROUS SCLEROSIS ASSOCIATION, INC., D/B/A TUBEROUS SCLEROSIS ALLIANCE, IS DEDICATED TO FINDING A CURE FOR TUBEROUS SCLEROSIS COMPLEX WHILE IMPROVING THE LIVES OF THOSE AFFECTED.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$2,752,226ExpenseAmt
Grant$535,454GrantAmt
Revenue$796,617RevenueAmt
DescRESEARCH PROGRAM - SEE SCHEDULE O PAGE 54Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$773,653ExpenseAmt
Revenue$9,774RevenueAmt
DescSUPPORT SERVICES - SEE SCHEDULE O PAGE 59Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$322,284ExpenseAmt
Revenue$2,600RevenueAmt
DescPUBLIC HEALTH EDUCATION - SEE SCHEDULE O PAGE 62Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$230,179TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$15,250TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$4,078,342TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document40IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee19EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members20GoverningBodyVotingMembersCnt
Independent Voting Member20IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsYes (true)ChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersYes (true)MembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonTHE ORGANIZATIONPersonNm
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 ROEDER ROAD STE 750AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (25 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
TIM DILLS
CHAIR5.00.0Yes (X)Yes (X)$0$0$0
BETH DEAN
VICE CHAIR5.00.0Yes (X)Yes (X)$0$0$0
DAVID FITZMAURICE
IMMEDIATE PAST CHAIR5.00.0Yes (X)Yes (X)$0$0$0
REBECCA ANHANG PRICE
SECRETARY5.00.0Yes (X)Yes (X)$0$0$0
JIM MAGINN
TREASURER5.00.0Yes (X)Yes (X)$0$0$0
MARTINA BEBIN MD MPA
BOARD MEMBER2.00.0Yes (X)$0$0$0
JOHN J BISSLER MD
BOARD MEMBER2.00.0Yes (X)$0$0$0
MICHAEL CAGGIANO
BOARD MEMBER2.00.0Yes (X)$0$0$0
CASSANDRA CARROLL
BOARD MEMBER2.00.0Yes (X)$0$0$0
SARA CHIEFFO
BOARD MEMBER2.00.0Yes (X)$0$0$0
MARGARET COX
BOARD MEMBER2.00.0Yes (X)$0$0$0
BONNIE HOGUE DUFFY
BOARD MEMBER2.00.0Yes (X)$0$0$0
TOM GWINN
BOARD MEMBER2.00.0Yes (X)$0$0$0
LAURA S LUBBERS
BOARD MEMBER2.00.0Yes (X)$0$0$0
BRENDAN D MANNING PHD
BOARD MEMBER2.00.0Yes (X)$0$0$0
DAVID MICHAELS
BOARD MEMBER2.00.0Yes (X)$0$0$0
DARREN MILES
BOARD MEMBER2.00.0Yes (X)$0$0$0
DEBORA L MORITZ
BOARD MEMBER5.00.0Yes (X)$0$0$0
JULIE SCROGGINS
BOARD MEMBER2.00.0Yes (X)$0$0$0
MATTHEW SIMONIAN
BOARD MEMBER2.00.0Yes (X)$0$0$0
KARI L ROSEBECK
PRESIDENT & CEO54.01.0Yes (X)$192,244$0$28,504
RICHARD A GOLLUB
CONTROLLER & CFO46.53.5Yes (X)$147,524$0$33,575
STEVEN L ROBERDS
CHIEF SCIENTIFIC OFFICER45.00.0$201,086$0$31,043Yes (X)
JAYE D ISHAM
VP, COMMUNICATIONS STRATEGY45.00.0$105,665$0$4,406Yes (X)
LISA MOSS
SR DIRECTOR OF DONOR RELATIONS45.00.0$101,755$0$23,366Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$748,274TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$120,894TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K5IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
PSYCHOGENICS INC
20 GRAMERCY PARK SOUTHNEW YORKNY10003RESEARCH LAB SVCS$901,513
VAN ANDEL RESEARCH INSTITUTE
333 BOSTWICK AVE NEGRAND RAPIDSMI49503RESEARCH$133,575
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K2CntrctRcvdGreaterThan100KCnt
Info In Schedule O Part VIIIYes (X)InfoInScheduleOPartVIIIInd
Federated Campaigns$37,803FederatedCampaignsAmt
Membership Dues$47,932MembershipDuesAmt
Fundraising$1,344,269FundraisingAmt
Related Organizations$403,000RelatedOrganizationsAmt
All Other Contributions$2,116,949AllOtherContributionsAmt
Noncash Contributions$115,787NoncashContributionsAmt
Total Contributions$3,949,953TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescCONTRACT REVENUEDesc
Business900099BusinessCd
Total Revenue Column$824,241TotalRevenueColumnAmt
Related Or Exempt Func Income$824,241RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$824,241TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,150TotalRevenueColumnAmt
Exclusion$10,150ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$243TotalRevenueColumnAmt
Exclusion$243ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$115,040SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$114,969SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$71SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$71TotalRevenueColumnAmt
Exclusion$71ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$118,113FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,344,269ContriRptFundraisingEventAmt
Fundraising Direct Expenses$160,609FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$42,496TotalRevenueColumnAmt
Exclusion-$42,496ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISCELLANEOUSDesc
Business900099BusinessCd
Total Revenue Column$642TotalRevenueColumnAmt
Exclusion$642ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$642OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,742,804TotalRevenueColumnAmt
Related Or Exempt Func Income$824,241RelatedOrExemptFuncIncomeAmt
Exclusion-$31,390ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$461,145TotalAmt
Program Services$461,145ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$74,309TotalAmt
Program Services$74,309ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$638,990TotalAmt
Program Services$347,872ProgramServicesAmt
Management And General$219,346ManagementAndGeneralAmt
Fundraising$71,772FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$932,810TotalAmt
Program Services$552,836ProgramServicesAmt
Management And General$109,302ManagementAndGeneralAmt
Fundraising$270,672FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$27,991TotalAmt
Program Services$17,634ProgramServicesAmt
Management And General$2,391ManagementAndGeneralAmt
Fundraising$7,966FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$105,088TotalAmt
Program Services$67,352ProgramServicesAmt
Management And General$1,074ManagementAndGeneralAmt
Fundraising$36,662FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$104,169TotalAmt
Program Services$59,589ProgramServicesAmt
Management And General$19,944ManagementAndGeneralAmt
Fundraising$24,636FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$78,839TotalAmt
Program Services$57,607ProgramServicesAmt
Management And General$21,232ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$19,500TotalAmt
Management And General$19,500ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$105,960TotalAmt
Program Services$105,960ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$171,240TotalAmt
Program Services$99,105ProgramServicesAmt
Management And General$25,717ManagementAndGeneralAmt
Fundraising$46,418FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$317,408TotalAmt
Program Services$120,073ProgramServicesAmt
Management And General$67,225ManagementAndGeneralAmt
Fundraising$130,110FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$129,324TotalAmt
Program Services$43,735ProgramServicesAmt
Management And General$85,589ManagementAndGeneralAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$94,281TotalAmt
Program Services$285ProgramServicesAmt
Management And General$93,712ManagementAndGeneralAmt
Fundraising$284FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$272,085TotalAmt
Program Services$227,893ProgramServicesAmt
Management And General$3,047ManagementAndGeneralAmt
Fundraising$41,145FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$242,361TotalAmt
Program Services$198,367ProgramServicesAmt
Management And General$34,708ManagementAndGeneralAmt
Fundraising$9,286FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$69,095TotalAmt
Program Services$35,516ProgramServicesAmt
Management And General$29,965ManagementAndGeneralAmt
Fundraising$3,614FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$8,025TotalAmt
Program Services$150ProgramServicesAmt
Management And General$7,716ManagementAndGeneralAmt
Fundraising$159FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PRECLINICAL CONSORTIUM$1,042,919$1,042,919
NATURAL HISTORY DATABASE$222,524$222,524
BIOSAMPLE REPOSITORY$120,771$120,771
OVERHEAD ALLOCATION$175,714-$248,016$72,302

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$82,463TotalAmt
Program Services$46,986ProgramServicesAmt
Management And General$16,669ManagementAndGeneralAmt
Fundraising$18,808FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$5,321,297TotalAmt
Program Services$4,078,342ProgramServicesAmt
Management And General$509,121ManagementAndGeneralAmt
Fundraising$733,834FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$78,960TotalAmt
Program Services$39,480ProgramServicesAmt
Fundraising$39,480FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,840,325BOYAmt
EOY$1,079,000EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$779,808BOYAmt
EOY$1,231,098EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,480,988BOYAmt
EOY$989,299EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$262,025BOYAmt
EOY$278,373EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$182,942BOYAmt
EOY$344,133EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$372,051LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$186,050LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$190,332BOYAmt
EOY$186,001EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$10,970EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$5,267,921BOYAmt
EOY$5,638,427EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,004,341BOYAmt
EOY$9,757,301EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$523,259BOYAmt
EOY$472,644EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$131,976BOYAmt
EOY$167,293EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$82,902BOYAmt
EOY$60,584EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$738,137BOYAmt
EOY$700,521EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,303,111BOYAmt
EOY$5,975,949EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,083,649BOYAmt
EOY$2,201,387EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$879,444BOYAmt
EOY$879,444EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$9,266,204BOYAmt
EOY$9,056,780EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,004,341BOYAmt
EOY$9,757,301EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$578,493ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$792NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$368,277OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,239,048CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,124,386CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,514,873CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,517,826CurrentTaxYearMinus1YearAmt
Current Tax Year$3,949,953CurrentTaxYearAmt
Total$18,346,086TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,239,048CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,124,386CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,514,873CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,517,826CurrentTaxYearMinus1YearAmt
Current Tax Year$3,949,953CurrentTaxYearAmt
Total$18,346,086TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$2,725,455SubstantialContributorsTotAmt
Public Support Total170$15,620,631PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$13,335CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$13,455CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$16,038CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$15,431CurrentTaxYearMinus1YearAmt
Current Tax Year$10,393CurrentTaxYearAmt
Total$68,652TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus1 Year$44,490CurrentTaxYearMinus1YearAmt
Total$44,490TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,984CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$9,351CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,401CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,683CurrentTaxYearMinus1YearAmt
Current Tax Year$642CurrentTaxYearAmt
Total$19,061TotalAmt
FieldValueIRS element (for citing)
Total Support$18,478,289TotalSupportAmt
Gross Receipts Rltd Activities$4,152,994GrossReceiptsRltdActivitiesAmt
Public Support CY1700.84535PublicSupportCY170Pct
Public Support PY1700.81282PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,797FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$146,199FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$147,996FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,173,301FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,321,297FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$416,065FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$104,016FilingOrganizationsTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$362,797CurrentYearMinus3Amt
Current Year Minus2$364,719CurrentYearMinus2Amt
Current Year Minus1$394,622CurrentYearMinus1Amt
Current Year$416,065CurrentYearAmt
Total$1,538,203TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$2,307,305LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$178,975CurrentYearMinus3Amt
Current Year Minus2$126,441CurrentYearMinus2Amt
Current Year Minus1$145,927CurrentYearMinus1Amt
Current Year$146,199CurrentYearAmt
Total$597,542TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$90,699CurrentYearMinus3Amt
Current Year Minus2$91,180CurrentYearMinus2Amt
Current Year Minus1$98,656CurrentYearMinus1Amt
Current Year$104,016CurrentYearAmt
Total$384,551TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$576,827GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$905CurrentYearMinus3Amt
Current Year Minus2$5,047CurrentYearMinus2Amt
Current Year Minus1$986CurrentYearMinus1Amt
Current Year$1,797CurrentYearAmt
Total$8,735TotalAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,293,989BeginningYearBalanceAmt
Contributions$92,635ContributionsAmt
Investment Earnings Or Losses$739,072InvestmentEarningsOrLossesAmt
Other Expenditures$403,000OtherExpendituresAmt
Administrative Expenses$67,141AdministrativeExpensesAmt
End Year Balance$5,655,555EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,763,517BeginningYearBalanceAmt
Contributions$58,749ContributionsAmt
Investment Earnings Or Losses$525,868InvestmentEarningsOrLossesAmt
Administrative Expenses$54,145AdministrativeExpensesAmt
End Year Balance$5,293,989EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,061,299BeginningYearBalanceAmt
Contributions$29,940ContributionsAmt
Investment Earnings Or Losses$93,294InvestmentEarningsOrLossesAmt
Other Expenditures$202,000OtherExpendituresAmt
Administrative Expenses$32,428AdministrativeExpensesAmt
End Year Balance$4,950,105EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,994,766BeginningYearBalanceAmt
Contributions$47,153ContributionsAmt
Investment Earnings Or Losses$179,553InvestmentEarningsOrLossesAmt
Other Expenditures$97,500OtherExpendituresAmt
Administrative Expenses$62,673AdministrativeExpensesAmt
End Year Balance$5,061,299EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,457,365BeginningYearBalanceAmt
Contributions$42,690ContributionsAmt
Investment Earnings Or Losses$718,381InvestmentEarningsOrLossesAmt
Other Expenditures$197,200OtherExpendituresAmt
Administrative Expenses$26,470AdministrativeExpensesAmt
End Year Balance$4,994,766EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.84450BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.15550PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgYes (true)EndowmentsHeldRelatedOrgInd
Related Org List Sch RYes (true)RelatedOrgListSchRInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$156,545OtherCostOrOtherBasisAmt
Depreciation$106,502DepreciationAmt
Book Value$50,043BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$71,461OtherCostOrOtherBasisAmt
Depreciation$19,279DepreciationAmt
Book Value$52,182BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$144,045OtherCostOrOtherBasisAmt
Depreciation$60,269DepreciationAmt
Book Value$83,776BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$186,001TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
INTEREST IN NET ASSETS OF AFFI$5,655,555
DUE FROM AFFILIATE-$17,128
FieldValueIRS element (for citing)
Total Book Value Other Assets$5,638,427TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENT & LEASE INCENTIVDesc
Amt$60,584Amt
FieldValueIRS element (for citing)
Total Liability$60,584TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$5,186,056TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$792NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$22,186DonatedServicesAndUseFcltsAmt
Other Revenue$823,274OtherRevenueAmt
Revenue Not Reported$846,252RevenueNotReportedAmt
Revenue Subtotal$4,339,804RevenueSubtotalAmt
Other Revenues Not Included$403,000OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$403,000RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$4,742,804TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$5,395,480TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$22,186DonatedServicesUseFcltsAmt
Other Expenses Included$58,708OtherExpensesIncludedAmt
Expenses Not Reported$80,894ExpensesNotReportedAmt
Expenses Subtotal$5,314,586ExpensesSubtotalAmt
Other Expenses Not Included$6,711OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$6,711ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$5,321,297TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:THE ALLIANCE'S ENDOWMENTS CONSIST OF TWO FUNDS ESTABLISHED FOR DIFFERENT PURPOSES. THE ALLIANCE'S ENDOWMENT INCLUDE ONE TRADITIONAL DONOR-RESTRICTED ENDOWMENT FUNDS AND ONE BOARD-DESIGNATED ENDOWMENT FUND. THE BOARD-DESIGNATED ENDOWMENT FUND SOLELY CONSISTS OF THE ENDOWMENT FUND'S UNRESTRICTED NET ASSET BALANCE.
PART X, LINE 2:Accounting principles generally accepted in the United States of America require management to evaluate income tax positions taken and accrue an income tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the Internal Revenue Service. Management has evaluated the income tax positions taken and concluded that as of December 31, 2017 there are no uncertain positions taken or expected to be taken that would require accrual of a liability in the consolidated financial statements. The Alliance is subject to routine audits by taxing jurisdictions; however, there are currently no audits in progress for any tax periods. As of December 31, 2017 the statute of limitations for tax years 2014 through 2016 remains open with the U.S. federal jurisdiction or the various states and local jurisdictions in which the Alliance files tax returns.
PART XI, LINE 2D - OTHER ADJUSTMENTS:$823,274 REVENUES FROM RELATED ORGANIZATION
PART XI, LINE 4B - OTHER ADJUSTMENTS:$403,000 RELATED ORGANIZATION GRANT ELIMINATED FOR CONSOLIDATED FINANCIAL STATEMENT.
PART XII, LINE 2D - OTHER ADJUSTMENTS:$ 461,708 EXPENSES FROM RELATED ORGANIZATION $(403,000) GRANT FROM RELATED ORGANIZATION ELIMINATED FOR FS PURPOSES --------- $ 58,708 =========
PART XII, LINE 4B - OTHER ADJUSTMENTS:$6,711 RETURNED GRANT FROM PRIOR YEAR

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmtSpecific Services ProvidedSpecificServicesProvidedTxt
Europe (Including Iceland and Greenland)Grantmaking$74,309
Europe (Including Iceland and Greenland)Program Services$34,155PRECLINICAL TESTING
FieldValueIRS element (for citing)
Subtotal Spent$108,464SubtotalSpentAmt
Total Spent$108,464TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEurope (Including Iceland and Greenland)RegionTxt
Purpose Of GrantRESEARCHPurposeOfGrantTxt
Cash Grant$74,309CashGrantAmt
Manner Of Cash DisbursementWIREMannerOfCashDisbursementTxt
Valuation Method UsedCASHValuationMethodUsedDesc
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationGRANTEE ORGANIZATIONS ARE EXPECTED TO FILE ANNUAL PROGRESS REPORTS TO OUTLINED GRANT GOALS AND MILESTONES. THESE REPORTS ARE REVIEWED BY A COMMITTEE OF PEERS. THIS COMMITTEE MAKES DETERMINATIONS BASED ON QUALITY OF WORK TO GOALS AND IF THE GRANTEE WILL CONTINUE TO RECEIVE FUNDING. A FINAL WRITTEN AND FINANCIAL REPORT IS REQUIRED OF ALL GRANTEES.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1WALKSEvent1Nm
Gross Receipts Event1$926,266GrossReceiptsEvent1Amt
Charitable Contri Event1$866,266CharitableContriEvent1Amt
Gross Revenue Event1$60,000GrossRevenueEvent1Amt
Non Cash Prizes Event1$48,476NonCashPrizesEvent1Amt
Rent Facility Costs Event1$18,712RentFacilityCostsEvent1Amt
Food And Beverage Event1$4,503FoodAndBeverageEvent1Amt
Entertainment Event1$4,362EntertainmentEvent1Amt
Event2COMEDY FOR CUREEvent2Nm
Gross Receipts Event2$200,433GrossReceiptsEvent2Amt
Charitable Contri Event2$175,972CharitableContriEvent2Amt
Gross Revenue Event2$24,461GrossRevenueEvent2Amt
Non Cash Prizes Event2$74NonCashPrizesEvent2Amt
Rent Facility Costs Event2$11,236RentFacilityCostsEvent2Amt
Food And Beverage Event2$26,413FoodAndBeverageEvent2Amt
Entertainment Event2$1,500EntertainmentEvent2Amt
Other Events Total10OtherEventsTotalCnt
Gross Receipts Other Events$335,683GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$302,031CharitableContriOtherEventsAmt
Gross Revenue Other Events$33,652GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$3,942NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$16,729RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$24,356FoodAndBeverageOtherEventsAmt
Entertainment Other Events$306EntertainmentOtherEventsAmt
Gross Receipts Total$1,462,382GrossReceiptsTotalAmt
Charitable Contributions Tot$1,344,269CharitableContributionsTotAmt
Gross Revenue Total Events$118,113GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$52,492NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$46,677RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$55,272FoodAndBeverageTotalEventsAmt
Entertainment Total Events$6,168EntertainmentTotalEventsAmt
Direct Expense Summary Events$160,609DirectExpenseSummaryEventsAmt
Net Income Summary-$42,496NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
BRIGHAM & WOMEN'S HOSPITAL
75 ST FRANCIS STREETBOSTONMA02115042312909501(C)(3)$75,000RESEARCH GRANTS
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75287756002868501(C)(3)$75,000RESEARCH GRANT
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413BOSTONMA02241042774441501(C)(3)$131,145RESEARCH GRANTS
PRESIDENT & FELLOWS OF HARVARD COLLEGE
PO BOX 415649BOSTONMA02241042103580501(C)(3)$100,000RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2150 SHATTUCK AV 300BERKELEYCA94704946002123501(C)(3)$75,000RESEARCH GRANT
FieldValueIRS element (for citing)
Total501c3 Org5Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE TS ALLIANCE HAS FUNDED MORE THAN $20.3 MILLION IN RESEARCH ON TSC SINCE 1984. DIRECTED BY STEVEN L. ROBERDS, PH.D, CHIEF SCIENTIFIC OFFICER, THE TS ALLIANCE RESEARCH GRANTS PROGRAM FUNDS RESEARCH FOCUSED ON TSC WITH PRIORITIES SET BY THE RESEARCHERS TOGETHER WITH THE TS ALLIANCE. COLLABORATIONS BETWEEN BASIC AND CLINICAL RESEARCHERS ARE ENCOURAGED AND FOSTERED, AND THE TS ALLIANCE IS WORKING TO INCREASE FUNDING FOR RESEARCH ON TSC. THROUGH THE TS ALLIANCE RESEARCH GRANTS PROGRAM, APPLICATIONS CAN BE SUBMITTED FOR: - POSTDOCTORAL FELLOWSHIPS - TSC RESEARCH GRANTS GRANTS ARE REVIEWED IN A THREE-STEP PROCESS: - A GRANT REVIEW COMMITTEE COMPOSED OF INDIVIDUALS KNOWLEDGEABLE ABOUT THE CLINICAL AND BASIC COMPONENTS OF TSC, REVIEW ALL GRANT APPLICATIONS FOR SCIENTIFIC MERIT, RELEVANCY TO THE FUNDING PRIORITIES OF THE ORGANIZATION AND WITH A FOCUS ON UNDERSTANDING THE MECHANISMS OF TSC AND/OR THE DEVELOPMENT OF TREATMENTS AND THERAPIES FOR THE MANIFESTATIONS OF THE DISEASE. - THE SCIENCE AND MEDICAL COMMITTEE OF THE BOARD OF DIRECTORS THEN REVIEWS THE GRANT REVIEW COMMITTEE'S CONCLUSIONS AND MAKES FUNDING RECOMMENDATIONS TO THE BOARD OF DIRECTORS. - THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS OF THE SCIENCE AND MEDICAL COMMITTEE AND MAKES FINAL APPROVAL FOR THE FUNDING OF GRANT APPLICATIONS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (true)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (true)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountOther Compensation Filing OrgOtherCompensationFilingOrgAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KARI L ROSEBECK
PRESIDENT & CEO$169,094$0$23,012$138$5,945$0$25,248$0$223,437$0$0$0
RICHARD A GOLLUB
CONTROLLER & CFO$129,671$0$17,457$396$4,647$0$31,617$0$183,788$0$0$0
STEVEN L ROBERDS
CHIEF SCIENTIFIC OFFICER$177,431$0$23,517$138$6,234$0$27,498$0$234,818$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 5A:KARI LUTHER ROSBECK, RICHARD GOLLUB, STEVE ROBERDS, JAYE ISHAM AND LISA MOSS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THE COMPENSATION COMMITTEE.
PART I, LINE 6A:KARI LUTHER ROSBECK, RICHARD GOLLUB, STEVE ROBERDS, JAYE ISHAM AND LISA MOSS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THE COMPENSATION COMMITTEE.
PART I & PART II:KARI LUTHER ROSBECK AND RICHARD GOLLUB ARE EMPLOYEES OF TUBEROUS SCLEROSIS ALLIANCE AND ARE COMPENSATED THROUGH TS ALLIANCE. THESE INDIVIDUALS SERVE THE ENDOWMENT WITHOUT COMPENSATION.

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution11ContributionCnt
Noncash Contributions Rpt F990$115,040NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescMISCELLANEOUS ITEMSDesc
Contribution2ContributionCnt
Noncash Contributions Rpt F990$747NoncashContributionsRptF990Amt
Method Of Determining RevenuesDONOR'S VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsfalseReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (13 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 4A, RESEARCH PROGRAM:Research Program stimulates and supports basic, translational, and clinical research on the various manifestations of tuberous sclerosis complex (TSC) to further the development of clinical therapies and, ultimately, a cure for TSC. Directed by Steven L. Roberds, PhD, Chief Scientific Officer, the TS Alliance research program funds research focused on TSC proposed by researchers and aligned with the research priorities of the TS Alliance. Collaborations between basic and clinical researchers are encouraged and fostered, for example, by biennial International TSC Research Conferences. The TS Alliance has funded more than $20.3 million in research grants on TSC since 1984. Through the TS Alliance research grants program, applications can be submitted for postdoctoral fellowships and research grants. Grants are reviewed in a three-step process: (1) all grant applications are reviewed by a committee comprised of scientists knowledgeable about the topic area for scientific merit and of adults affected by TSC for potential impact on the lives of those affected by TSC; (2) the Science and Medical Committee of the Board of Directors evaluates the grant review committees recommendations and the relevance of the applications to the TS Alliances funding priorities; and (3) the Board of Directors then reviews the recommendations of the Science and Medical Committee and makes final approval for funding. A total of 8 research awards were funded during 2017. In 2016, Dr. Peter Davis (Boston Childrens Hospital) was awarded one year of funding to study brain network biomarkers of epilepsy in TSC to identify those at highest risk of developing seizures. In 2017, he applied for and was granted an additional year of funding to extend his work to correlate EEG network biomarkers with epilepsy severity and treatment response. The Board of Directors approved funding to begin in 2018 for three additional projects. Also in 2017, we continued to support six research grants awarded in previous years. Implemented in 2006, the TSC Natural History Database captures clinical data to document the impact of the disease on a persons health over their lifetime. As of December 2017, 2,124 people with TSC were enrolled in the project from among 18 U.S.-based sites. The TS Alliance provides funding to participating clinics to perform data entry, monitors the integrity of the database, and makes data available to investigators to answer specific research questions and identify potential participants for clinical trials and studies. In 2017, the TS Alliance invested $222,524 in the TSC Natural History Database and implemented sub-projects on TAND and epilepsy while continuing sub-projects on renal angiomyolipomas and subepyndymal giant cell astrocytomas to address detailed questions about these life-threatening manifestations of TSC. A contract with Novartis executed in November 2012 provided TS Alliance with funding to enhance and grow the depth of data in the TSC Natural History Database through 2018. The TSC Biosample Repository is a TS Alliance-directed project initiated in 2014 that will impact research over the next ten years or more. High-quality biosamples such as blood, DNA, and tissues linked to detailed clinical data are required for researchers to understand why TSC is so different from person to person. The TS Alliances Science and Medical Committee identified this as a gap that can only be filled effectively with leadership of the TS Alliance, guided by a steering committee of clinicians and researchers. The TSC Biosample Repository ended 2017 with 397 biosamples: 251 blood, buccal cell, or tissue samples from individuals with TSC enrolled in the TSC Natural History Database, and an additional 146 samples from the Rare Disease Clinical Research Networks Developmental Synaptopathies Consortium and the Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis Complex (PREVeNT) clinical trial. Samples in the repository are linked to detailed clinical data in our existing TSC Natural History Database and are available to qualified researchers worldwide. Samples are housed at and distributed from the Van Andel Institute in Grand Rapids, Michigan, under control of the TS Alliance. The TS Alliance launched the TSC Preclinical Consortium in 2015, which enables prioritization of candidate treatments based on comparing head-to-head data using consistent animal models and rigorous testing procedures. The TS Alliance is ideally positioned to drive this collaboration - with input from academic, regulatory, and industry stakeholders - by maintaining constant focus on the needs of people with TSC. To drive this project, the TS Alliance contracted with Dr. Daniela Brunner, who has more than 20 years of experience validating in vivo experimental protocols and testing drugs in many animal models of developmental, psychiatric, and neurodegenerative diseases. The TS Alliance has licenses to use specific TSC mouse models for experiments carried out by the Preclinical Consortium, and all mouse license agreements include the rights for the TS Alliance to perform experiments under contract for commercial entities. This ensures data generated by the Preclinical Consortium can be used to accelerate the development of new treatments by commercial entities as well as academic investigators. The consortium began running epilepsy experiments in August 2016 at PsychoGenics, a contract research organization. Tumor experiments began in August 2017 at Porsolt, another contract research organization. Three pharmaceutical companies joined the Preclinical Consortium in 2017, bringing the total to six industry partners. The TSC Preclinical Research Consortium ran ten studies in 2017, compared to just four in 2016. Some of the consortiums early results were shared by TS Alliance and PsychoGenics scientists at the National Organization for Rare Disorders conference, the Society for Neuroscience annual meeting, and the American Epilepsy Society annual meeting in Washington, DC. The TS Alliance continued to be a key part of the TSC Clinical Research Consortium although only a small amount of TS Alliance financial support was required because of the consortiums success in obtaining NIH funding. Now consisting of seven sites - Boston Childrens Hospital, Cincinnati Childrens Hospital, the University of Alabama at Birmingham, the University of Texas Health Science Center at Houston, UCLA, Stanford University, and Minnesota Epilepsy Group - the consortium has received $29 million in competitive grant funding from the National Institutes of Health (NIH) to support clinical studies in TSC. The Clinical Research Consortium is making history with the PREVeNT trial - preventing epilepsy using vigabatrin in infants with tuberous sclerosis complex. PREVeNT is the first preventative trial for any form of epilepsy in the US and began enrolling participants in December 2016. The PREVeNT trial builds directly upon the Consortiums first clinical study from which interim results have been published (www.ncbi.nlm.nih.gov/pubmed/26498039) showing that all infants who developed abnormal activity on EEGs went on to develop seizures. This trial will determine whether treatment with vigabatrin prior to the onset of clinical seizures in TSC is beneficial to childrens developmental and neurologic outcomes. The TS Alliances Chief Scientific Officer serves on the consortiums leadership team. The TS Alliance and The LAM Foundation jointly sponsored the 2017 International Research Conference on TSC and LAM: Innovating through Partnerships, held June 22-24, 2017, at the Hyatt Regency Capitol Hill in Washington, DC. More than 200 people, including 183 professional attendees from 27 countries, participated in scientific sessions featuring oral presentations, a poster session, and working groups of researchers tackling specific issues related to genetic, multidisciplinary clinical care, and translational research strategies. The conference concluded with a joint session including individuals and families affected by tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM). This session highlighted how quickly the fields of TSC and LAM treatment are moving and emphasized the need for further collaboration between individuals with TSC or LAM and their families, clinicians and researchers to accelerate the development of greatly improved treatments for these disorders. EXPENSES $2,752,226. INCLUDING GRANTS OF $535,454 REVENUES $796,617.
FORM 990, PART III, LINE 4B, SUPPORT SERVICES:Support Services develops programs and services that provide individuals with TSC direct access to information, resources, and specialists experienced in the diagnosis, treatment and management of TSC. The Support Services Department provided support and resources to 3,547 individuals and families dealing with TSC throughout 2017. The Vice President, Support Services attended 74 school meetings (IEPs, Evaluation Team Meetings, 504 Plan Meetings, Resolution Meetings, and Mediations) in person, through SKYPE or Facetime, and via conference calls to support families in attaining educational services for their children throughout the country. Through collaborations with the Parent Training and Information Centers in 2017, 3,005 free parent trainings/webinars on educational advocacy were offered to families in 32 states dealing with educational issues for their children. In addition, 128 school systems offered the support of the Educator Mentor Program in 2017. The Vice President, Support Services provided four school systems with training on "TSC and Learning" to hlep provide better educational outcomes for students with TSC. Through a network of 37 volunteer branches of the organization, called Community Alliances, local education and support group meetings were held throughout the country. Through these Community Alliances, the TS Alliance hosted 57 educational meetings and gatherings throughout the year. In 2017, the TS Alliance of Maryland was launched, and the TS Alliance of DC Metro and TS Alliance of Virginia were merged to reflect the overlapping constituencies. The TS Alliance facilitated 20,247 peer-to-peer supports from Adult Regional Coordinators, Clinic Ambassadors, Dependent Adult Transition Resource Coordinators, and through the Community Alliances. In 2017, the TS Alliance hosted two Regional TSC and LAM Conferences in Houston, TX and Washington, DC with 118 combined attendees. These conferences, co-hosted by The LAM Foundation, brought together individuals, parents, caregivers and members of the medical community to provide the most up-to-date information so parents and adults with TSC and LAM can make informed decisions when evaluating treatment options. These one-day symposiums offered educational outreach, information on the latest treatments in TSC and LAM, research updates, and support options. Regional TSC and LAM Conferences provide much-needed forums for the growing number of people facing the daily challenges of TSC. The TS Alliance also held two Transition Workshops in New York, NY and San Diego, CA. The combine dattendance at these workshops was 58. The goal of these all-day transition workshops was to give parents and caregivers tangible resources to empower them with resources, clear timelines and next steps to develop an effective transition plan for their children. The TS Alliance partnered with Arc USA, Child Neurology Foundation and Mass Mutual because these organizations have pre-existing tools and best practices to assist through different aspects of the transition plan, and their expertise was vital to families in attendance. Global Outreach works to address unmet needs within the global TSC community. The program provides the opportunity for the TS Alliance to share experiences and assist in the start-up of support of TSC-related organizations in other countries. A global alliance is a structured group of empowered and caring volunteers who work closely with the TS Alliance to facilitate local connections for individuals and families affected by TSC, and raise revenue and awareness while supporting the mission of the organization. In 2017, the TS Alliance signed a global agreement with the Hungarian Foundation for Tuberous Sclerosis. The TS Alliance now has five global partnerships, including: TS Alliance of Israel, TS Canada ST, TS Alliance of Mexico, TS Alliance Foundation (in Thailand) and the Hungarian Foundation for Tuberous Sclerosis. EXPENSES $773,653. INCLUDING GRANTS OF $-0- REVENUES $9,774.
FORM 990, PART III, LINE 4C, PUBLIC HEALTH EDUCATION:Public Health Education heightens awareness of TSC throughout the general public to broaden the scope of support and understanding beyond TSC individuals and their families. During 2017, the TS Alliance produced three issues of its national magazine, Perspective, which is mailed to almost 17,000 constituents as well as posted on the website. The TS Alliances website increases awareness and provides extensive education through an average of more than 30,000 unique visitors each month. The TS Alliance also relies heavily on social media to educate constituents and promote new resources and events. Its Facebook Group boasts more than 8,600 members, while its Twitter account has 1,800-plus followers. To increase public awareness, the TS Alliance once again participated in TSC Global Awareness Day on May 15 as well as TSC Awareness Month thoughout May; a TSC Global Awareness Day news release garnered 12.1 million impressions. The TS Alliance again heavily promoted Infantile Spasms Awareness Week, December 1 to 7. This awareness campaign included targeted social media outreach and a satellite media tour, which gained coverage from 16 media outlets reaching a potential of 1.2 million. A news release about the TS Alliance's "Voice of the Patient Report" being submitted to the FDA resulted in 18.8 million media impressions. EXPENSES $322,284. INCLUDING GRANTS OF $-0- REVENUES $2,600.
FORM 990, PART III, LINE 4D, OTHER PROGRAM SERVICES:Government Relations focuses on educating members of Congress about TSC to further TSC research, awareness and clinical care. The annual TS Alliance March on Capitol Hill to advocate for federal funding for the Tuberous Sclerosis Complex Research Program (TSCRP) at the Department of Defenses (DoD) Congressionally Directed Medical Research Program (CDMRP) took place in late February 2017. More than 100 members of the TSC community participated and asked their senators and representatives to sign onto Dear Colleague letters in support of the TSCRP. Many other advocates who were not able to travel to Washington, DC met with their senators and representatives in their home states to make the case for continued funding. In the House, 160 Democratic and Republican Representatives signed a bipartisan Dear Colleague letter of support from Representatives Dave Loebsack (D-IA) and Ileana Ros-Lehtinen (R-FL). The Senate letter was sponsored by Senators Chris Murphy (D-CT) and Johnny Isakson (R-GA) and ended with 24 signatures. In FY2017, the TSC Research Program at the CDMRP received a $6 million appropriation, bringing the cumulative funding to $71 million since 2002 as a result of our successful grassroots efforts. Funding for FY2018 is pending on Congress passing the FY2018 budget but is currently included in the Houses 2018 Defense Appropriations Act at $6 million. Research performed through this program has recently led to additional clinical trials including determining if imatinib, a drug FDA-approved for cancer, can safely improve levels of VEGF-D, a biomarker of lymphangioleiomyomatosis (LAM), a life-threatening lung manifestation of TSC, funded in FY2013; testing a combination of two drugs to treat LAM funded in FY2012; a multi-site clinical trial testing the efficacy of an experimental topical rapamycin cream to treat the disfiguring facial tumors, called facial angiofibromas, caused by TSC funded in FY2010; a clinical research network was created to test potential new therapies, to validate biomarkers, and to learn the natural history of leading to a clinical trial funded in FY2012. Building upon FY2010-funded research on glutamate receptors (mGluR5), several companies are now looking at the link between cognitive impairments in TSC to autism, anxiety, and other mental disorders. The TSCRP has also funded research to develop animal models of TSC that have seizures, enabling a better understanding of the etiology of TSC. Based on data from TSCRP-funded animal models of TSC that have seizures and share pathology related to that of traumatic brain injury, an industry-sponsored clinical trial demonstrated the effectiveness the mTOR inhibitor, everolimus, at treating epilepsy in many individuals with TSC. None of this progress would have been possible without the critical support provided through the TSCRP. Additional Government Relations efforts included a Congressional Briefing, in partnership with the Infantile Spasms Action Network, on Capitol Hill on December 5, 2017. Congressional staff and key members of the TSC research and grassroots communities attended the event. Professional Education expands programs to target researchers and healthcare providers caring for individuals with TSC, medical students, genetic counselors and educators to minimize the consequences of ignorance and misinformation. The TS Alliance participated in and presented at 36 professional meetings including: American Thoracic Society and the ATS Leadership Summit; Child Neurology Society; Society for Neuroscience; National Arc Convention; Global Geners; NINDS Biomarkers Workshop; NICHD Workshop "Looking to the Future: The Next 50 Years of Intellectual and Developmental Disabilities Research Trans-NIH TSC meeting; Health Research Alliance members meetings; Research Roundtable in Epilepsy; Association of Clinical Research Professionals; Externally-Led Patient Focused Drug Development Meeting on TSC and LAM; International Research Conference on TSC and LAM; TSC/LAM Regional Conference in Houston; PKD Foundation; ICARE (Interagency Collaborative to Advance Research in Epilepsy); NINDS Nonprofit Forum; NCATS Toolkit for Patient-Focused Therapy Development; FDA CDER Public Workshop: Strategies, Tools, and Best Practices for Effective Advocacy in Rare Diseases Drug Development; Children's Tumor Foundation Research Consortium; Epilepsy Foundations Cannabinoid Signaling in Epilepsy workshop; World Orphan Drug Congress; NORD Orphan Products and Breakthrough Summit; Simons Foundation workshop on patient registries for neurodevelopmental disorders; Open Research Funders Group; BIO Patient Health and Advocacy Summit; the Arc National Convention; Infantile Spasms Action Network; REN Outcomes in Epilepsy Workshop; Refractory Epilepsy in Children at Sourasky Medical Center in Israel; LGS Family Conference; and The LAM Foundation Patient Benefit Conference and LAMposium LA. In addition, at the American Epilepsy Society meeting the TS Alliance presented in the Discovery Center and the poster session, and hosted more than 100 guests at a reception for TSC researchers. At the conference the TS Alliance also participated in a Special Interest Group meeting on TSC. In addition, the Vice President, Support Services continues to collaborate with national educational networks, including The Arc USA, Parent Training Information Centers across the country and the Association for Middle Level Education. EXPENSES $230,179. INCLUDING GRANTS OF $-0- REVENUES $15,250.
FORM 990, PART VI, SECTION A, LINE 4:THE BYLAWS OF NATIONAL TUBEROUS SCLEROSIS ASSOCIATION, INC. WERE AMENDED AS OF OCTOBER 2017 FOR THE FOLLOWING: 1. UPDATED THE LANGUAGE REGARDING ESTABLISHMENT AND TERMS OF MEMBERSHIP IN THE ORGANIZATION, THE RENEWAL PROCESS FOR MEMBERSHIP AND THAT "LIFETIME MEMBERS" ARE NOT REQUIRED TO SUBMIT MEMBERSHIP RE-APPLICATIONS. 2. CREATED NEW SECTION UNDER ORGANIZATION AND MEMBERSHIP TO RECLASS THE MANNER OF MEMBER VOTING AND EXPANDED THE LANGUAGE ON THE VOTING PROCESS. 3. CREATED NEW SECTION UNDER ORGANIZATION AND MEMBERSHIP FOR MEETINGS CONDUCTED BY ELECTRONIC TRANSMISSION.
FORM 990, PART VI, SECTION A, LINE 6:MEMBERSHIP IS AVAILABLE TO ANY PERSON WHO SUBSCRIBES TO THE PURPOSES AND OBJECTIVES OF THE CORPORATION, WITHOUT REGARD TO RACE, RELIGION, GENDER, SEXUAL ORIENTATION, AGE, COLOR, NATIONAL ORIGIN OR MENTAL OR PHYSICAL HANDICAP OR DISABILITY. THERE SHALL BE NO LIMIT TO THE NUMBER OF MEMBERS IN THE CORPORATION. 1) THERE MAY BE ONE OR MORE CLASSES OF MEMBERSHIP AS DETERMINED BY THE BOARD. 2) MEMBERSHIP IS NOT TRANSFERABLE OR ASSIGNABLE.
FORM 990, PART VI, SECTION A, LINE 7A:THE TS ALLIANCE IS A MEMBERSHIP-BASED ORGANIZATION, WHICH MEANS MEMBERS HELP ELECT THE BOARD OF DIRECTORS. THE TS ALLIANCE MEMBERSHIP PROGRAM ALLOWED INDIVIDUALS TO STATE THEIR INTENT TO BE A MEMBER FOR THE PURPOSE OF GOVERNANCE. THERE WERE NO LEVELS TO MEMBERSHIP IN 2017. ANYONE CAN BE A MEMBER AT NO COST.
FORM 990, PART VI, SECTION B, LINE 11:THE FORM 990 IS REVIEWED, IN DETAIL, BY THE BOARD OF DIRECTORS' AUDIT COMMITTEE. RECOMMENDATIONS ARE MADE BY THE COMMITTEE MEMBERS FOR ANY CHANGES/EDITS/ADDITIONS. AFTER THOSE HAVE BEEN INCORPORATED, THE AUDIT COMMITTEE VOTES WHETHER TO APPROVE AND THEN FORWARD THE 990 TO THE FINANCE AND EXECUTIVE COMMITTEES. THE FINANCE AND EXECUTIVE COMMITTEES PERFORM THE FINAL REVIEW AND THEN VOTE WHETHER TO APPROVE ON BEHALF OF THE BOARD OF DIRECTORS. A COPY OF THE APPROVED 990 IS SHARED WITH THE ENTIRE BOARD.
FORM 990, PART VI, SECTION B, LINE 12C:ANNUALLY EACH MEMBER OF THE BOARD OF DIRECTORS WILL RECEIVE NOTICE OF THE ORGANIZATION'S CONFLICT OF INTEREST STATEMENT. EACH MEMBER WILL BE PROVIDED WITH A STATEMENT TO MAKE DISCLOSURE OF ANY POTENTIAL CONFLICT OF INTEREST. IF DURING THE COURSE OF THE YEAR A POTENTIAL CONFLICT OF INTEREST ARISES THAT HAS NOT PREVIOUSLY BEEN DISCLOSED, THE BOARD MEMBER WILL MAKE WRITTEN NOTICE OF A POTENTIAL CONFLICT OF INTEREST AND RECUSE HIMSELF OR HERSELF FROM ANY DISCUSSIONS AND VOTES IN CONNECTION WITH THE ISSUE IDENTIFIED. ANY TIME A MEMBER IS RECUSED FROM DISCUSSION ON AN ISSUE, THE MINUTES OF COMMITTEE MEETING AND BOARD MEETING WILL DULY RECORD SUCH ACTIONS. THE FOLLOWING POTENTIAL CONFLICTS OF INTEREST WERE DISCLOSED FOR 2017: BOARD MEMBER BRENDAN MANNING, PH.D, IS EMPLOYED AT HARVARD COLLEGE, WHICH RECEIVED $100,000 ROTHBERG COURAGE AWARD GRANT TO STUDY REPURPOSING APPROVED INHIBITORS OF PURINE SYNTHESIS FOR TSC TREATMENT. BOARD MEMBER MARTINA BEBIN, MD IS EMPLOYED BY THE UNIVERSITY OF ALABAMA BIRMINGHAM, WHICH RECEIVED A $6,700 FEE FOR SERVICE FOR ENTERING DATA INTO THE NATURAL HISTORY DATABASE AND A $5,000 GRANT TO PROVIDE TRANSPORTATION TO PARTICIPANTS IN THE PREVENT STUDY. COMMITTEE MEETING AND BOARD MEETING WILL DULY RECORD SUCH ACTIONS.
FORM 990, PART VI, SECTION B, LINE 15:THE COMPENSATION COMMITTEE REVIEWS AND APPROVES THE SALARIES OF THE PRESIDENT/CEO, CHIEF SCIENTIFIC OFFICER, CONTROLLER & CFO, AND ANY EMPLOYEE APPEARING ON THE FORM 990, IN ACCORDANCE WITH THE TUBEROUS SCLEROSIS ALLIANCE BYLAWS. SUCH REVIEW AND APPROVAL OCCURS INITIALLY UPON HIRING, UPON ANNUAL REVIEWS AND WHENEVER MODIFIED. THE ORGANIZATION'S EXECUTIVE REMUNERATION HAS BEEN STRUCTURED TO ENSURE THAT IT: IS REASONABLE; PROVIDES A COMPETITIVE COMPENSATION PROGRAM TO RETAIN, ATTRACT AND REWARD KEY EMPLOYEES AND ACHIEVES CLEAR ALIGNMENT BETWEEN TOTAL REMUNERATION AND DELIVERED BUSINESS AND PERSONAL PERFORMANCE OVER THE SHORT AND LONG-TERMS. THE COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE TO ENSURE: - COMPARABILITY, - PROPER REVIEW, AND - SUBSTANTIATION IN SETTING THE COMPENSATION.
FORM 990, PART VI, SECTION C, LINE 19:ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON WRITTEN REQUEST.
FORM 990, PART XI, LINE 9, CHANGES IN NET ASSETS:$361,566 CHANGE IN INTEREST IN AFFLIIATE $ 6,711 PRIOR YEAR GRANT RETURNED -------- $368,277 TOTAL OTHER CHANGES IN NET ASSETS ========
FORM 990, PART XII, LINE 2CTHE AUDIT REVIEW PROCESS HAS REMAINED UNCHANGED FROM THE PRIOR YEAR.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1TUBEROUS SCLEROSIS ALLIANCE ENDOWMENT FDBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 ROEDER ROAD STE 750AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
EIN521926919EIN
Primary ActivitiesSUPPORT ORGPrimaryActivitiesTxt
Legal Domicile StateMDLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity Status11B, IIIPublicCharityStatusTxt
Controlled OrganizationfalseControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (true)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (true)SharingOfFacilitiesInd
Paid Employees SharingYes (true)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

FieldValueIRS element (for citing)
Business Name Line1TUBEROUS SCLEROSIS ALLIANCE ENDOWMENT FUNDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transaction TypeCTransactionTypeTxt
Involved$403,000InvolvedAmt
Method Of Amount DeterminationCASHMethodOfAmountDeterminationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.